General discussion, page-13225

We’ve just had 4 significant pieces of news.

1. Highly significant in-human OSA results
2. NASDAQ listing
3. Acquisition of APIRx
4. Loyalty option entitlement

Major clinical results are a long and exhaustive process. Do you think the board and medical team just knock these up in Joel’s garage?

These guys have done an outstanding job in a very quick period of time. And the share price performance has been phenomenal.